Tag: Anthera Pharmaceuticals
March 6, 2018
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results
Anthera Pharmaceuticals (Nasdaq:ANTH) today provided a business update and reported financial results for the fourth quarter and fiscal year ending... January 25, 2018
Anthera Receives Positive Nasdaq Listing Determination
Anthera Pharmaceuticals (Nasdaq:ANTH) today announced that on January 24, 2018, Anthera received formal notice that the Nasdaq Hearings Panel granted Anthera’s... January 22, 2018
Anthera Announces Positive Outcome of Second Interim Futility Analysis in the Phase 3 RESULT Clinical Study of Sollpura
Anthera Pharmaceuticals (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for the RESULT Phase 3... April 10, 2017